The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
Childs
David W
DW
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000972:Antineoplastic Agents, Phytogenic; D003132:Commerce / Q000331:legislation & jurisprudence; D003906:Developing Countries; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D005062:European Union; D006801:Humans; D006814:Hungary; D018973:Intellectual Property; D038622:Internationality; D007880:Legislation, Drug; D017239:Paclitaxel; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*; D012066:Relief Work / Q000458:organization & administration; D014481:United States; D014944:World Health Organization
D000972:Antineoplastic Agents, Phytogenic; D016568:Drugs, Generic; D004364:Pharmaceutical Preparations; D017239:Paclitaxel